BP 2001

Drug Profile

BP 2001

Alternative Names: BioPancreate-2001; BP-2001

Latest Information Update: 29 Mar 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cortendo
  • Developer Strongbridge Biopharma
  • Class Bacteria
  • Mechanism of Action Gene expression modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Type 1 diabetes mellitus; Type 2 diabetes mellitus

Most Recent Events

  • 11 Mar 2016 BP 2001 is available for licensing in USA
  • 04 Sep 2015 Cortendo is now called Strongbridge Biopharma
  • 02 Feb 2015 BP 2001 is available for licensing as of 28 Jan 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top